SCTPF Stock News Stem Cell Therapeuti (SCTPF) 0.2750 07/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Stem Cell Therapeuti (SCTPF) 0.2750 $SCTPF

Trillium Therapeutics Receives Prestigious National Award
Marketwire - Fri Jun 13, 9:01AM CDT
Trillium Therapeutics Inc. ("TTI" (TSX: TR)(OTCQX: SCTPF), an immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has been awarded BIOTECanada's 2014 Gold Leaf Award as Early Stage Health Company of the Year.

Stem Cell Therapeutics Changes Its Name to Trillium Therapeutics Inc.
Marketwire - Thu Jun 05, 1:37AM CDT
Stem Cell Therapeutics Corp. ("SCT" (TSX: SSS)(OTCQX: SCTPF), an immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that it has filed articles of amalgamation to merge with its wholly-owned subsidiary Trillium Therapeutics Inc. ("TTI" . The combined company has adopted the Trillium name.

Stem Cell Therapeutics Announces Results of Annual Shareholders Meeting
Marketwire - Wed May 28, 7:46AM CDT
Stem Cell Therapeutics Corp. ("SCT" (TSX: SSS)(OTCQX: SCTPF), an immuno-oncology company developing innovative therapies for the treatment of cancer, today announced that the company's annual and special meeting of shareholders held yesterday voted to support all of the resolutions proposed to shareholders.

Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report 2014
M2 - Mon May 19, 3:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/vwbmb9/circulating_tumor) has announced the addition of the "Circulating Tumor Cells and Cancer Stem Cells Technologies - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Circulating Tumor Cells and Cancer Stem Cells Technologies in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Key Topics Covered: Click the link below to view the full, extended table of contents. I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS II. EXECUTIVE SUMMARY 1. CIRCULATING TUMOR CELLS (CTCS) GLOBAL MARKET OVERVIEW - Real-Time Liquid Biopsy' Scores Over Surgical Biopsy - Challenges in CTC Diagnostics - Need for CTC Enrichment and Popular Methods 2. MARKET TRENDS AND DRIVERS - CTCs for Personalized Cancer Treatment - Microfluidic Chip-based Technologies - A Promising Avenue for Cancer Diagnosis - CTC Microdevices Hog the Limelight 3. CANCER STEM CELLS GLOBAL MARKET OVERVIEW - CSC-Focused Innovations in Cancer Therapeutics - Select Pathways or Molecular Targets for CSC Candidates - Pipeline Analysis of Select Cancer Stem Cells Therapeutics ( 2014) 4. CTC AND CSC RESEARCH FINDINGS & BREAKTHROUGHS - Microfluidic Device with Micro-Hall Sensors Detect CTCs with Higher Sensitivity and Specificity - NBiomics Makes its Contribution to CTC Diagnosis - Researchers at University of Michigan Develop Revolutionary Capture CTCs Method 5. MEDICAL DIAGNOSTICS MARKET A CONCEPTUAL OVERVIEW - Molecular Diagnostics for Lymphoid Malignancies - Market Trends & Issues - Global Molecular Diagnostics on a High Growth Curve - Automation Driving Global Market - Molecular Diagnostics: Marking Convergence of Numerous Technologies 6. CIRCULATING TUMOR CELL (CTC) DIAGNOSTICS ENRICHMENT, IDENTIFICATION AND CHARACTERIZATION METHODS - Filtration (iSET) - Density Gradient - Immuno-magnetic Cell Enrichment - Advantages of Different CTC Enrichment Procedures - AdnaTest 7. CANCER STEM CELLS (CSCS) BIOLOGY, ISOLATION, CSC SURFACE MARKERS, AND SIGNALING PATHWAYS - Differences between Normal Stem Cells and Cancer Stem Cells - Hierarchical versus Stochastic Models of Tumour Cell Heterogeneity - Isolation of Cancer Stem Cells - Characteristics of Cancer Stem Cells - Resistance to Chemotherapy - Resistance to Radiation - Invasion or Metastatic Activity 8. PRODUCT LAUNCHES AND INTRODUCTIONS - EU Authorisation for ANGLE's Parsortix Cancer Diagnostic Device - ANGLE Launches Parsortix Device into the Research Market - Promab Introduces New Range of Cancer Stem Cells Solutions - Clearbridge BioMedics Unveils ClearCell? FX Cancer Cell Enrichment System - Fluxion Introduces New IsoFlux System CTC Technology - Cynvenio Launches LiquidBiopsy Lab Service - Biocept Launches OncoCEE-BR - ApoCell to Launch ApoStream 9. RECENT INDUSTRY ACTIVITY - Stem Cell Therapeutics and University of York Ink Option Agreement - Veridex Undergoes Name Change to Janssen Diagnostics - Janssen Diagnostics and Arno Therapeutics Ink Collaboration Agreement - Veridex Enters into Agreement with LabCorp - Stemline Therapeutics Obtains Orphan Drug Designation for SL-401 10. FOCUS ON SELECT MAJOR PLAYERS IN CTC DIAGNOSTICS - Adnagen GmbH (Germany) - ApoCell, Inc (US) - Biocep LTD (Israel) - Biocept, Inc. (US) - Biofluidica Microtechnologies LLC (US) - Celltrafix Inc. (US) - Clearbridge Biomedics (Singapore) - Creatv Microtech, Inc (US) - Cynvenio Biosystems, Inc. (US) - Ikonisys, Inc. (US) - IVDiagnostics, Inc. (US) - Janssen Diagnostics LLC (US) - Epic Biosciences Inc (US) - RARECELLS SAS (Italy) - SCREENCELL (France) - Stemcell Technologies, Inc. (Canada) 11. SELECT MARKET PARTICIPANTS IN THE CANCER STEM CELLS (CSCS) SPACE - Alchemia Limited (Australia) - Amgen Inc. (US) - Exelixis, Inc. (US) - Formula Pharmaceuticals (US) - GlaxoSmithKline Plc. (UK) - Geron Corp. (US) - Infinity Pharmaceuticals (US) - Kalobios Pharmaceuticals Inc. (US) - Novartis AG (Switzerland) - OncoMed Pharmaceuticals, Inc. (US) - Pfizer, Inc. (US) - Roche Diagnostics (Switzerland) - Verastem, Inc. (US) 12. GLOBAL MARKET PERSPECTIVE III. MARKET 1. THE UNITED STATES 2. CANADA 3. JAPAN 4. EUROPE 5. ASIA-PACIFIC 6. REST OF WORLD IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 66 (including Divisions/Subsidiaries 67) - The United States (46) - Canada (3) - Japan (2) - Europe (9) - France (3) - Germany (2) - The United Kingdom (1) - Rest of Europe (3) - Asia-Pacific (Excluding Japan) (4) - Middle East (3) For more information visit http://www.researchandmarkets.com/research/vw...ting_tumor

Stem Cell Therapeutics Strengthens its Board of Directors
Marketwire - Mon Mar 10, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that Mr. Luke Beshar and Dr. Thomas Reynolds have been appointed to the Company's Board of Directors.

Stem Cell Therapeutics Announces Appointment of Dr. Calvin R. Stiller as Chairman
Marketwire - Thu Jan 30, 6:38AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, is pleased to announce that its Board of Directors has elected Dr. Calvin R. Stiller as Chairman of the Board. Dr. Stiller has been a member of the Board since July 2011 and served as Lead Director and Chair of the Governance and Nominating Committee.

Stem Cell Therapeutics Announces Resignation of Director
Marketwire - Mon Jan 27, 6:01AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, announces that effective today, Mr. David Allan has resigned from its board of directors.

Stem Cell Therapeutics Provides Corporate Update
Marketwire - Mon Jan 13, 6:01AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today provided the following six-month corporate update:

Stem Cell Therapeutics Appoints Dr. Robert Kirkman to Its Board of Directors
Marketwire - Tue Dec 17, 6:01AM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell-related therapeutics, today announced that industry veteran Dr. Robert L. Kirkman has been appointed to the Company's Board of Directors.

Stem Cell Therapeutics Completes $33 Million Private Placement
Marketwire - Fri Dec 13, 3:50PM CST
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), an immuno-oncology company developing cancer stem cell- related therapeutics, is pleased to announce that it has raised gross proceeds of $33 million through a private placement of units. The financing proceeds will be used to advance the Company's CD47 cancer stem cell program through IND-enabling studies, manufacturing and phase 1 clinical trials.

Stem Cell Therapeutics Adopts Shareholder Rights Plan
Marketwire - Tue Sep 17, 6:01AM CDT
Stem Cell Therapeutics Corp. (TSX VENTURE: SSS)(OTCQX: SCTPF), a biopharmaceutical company developing cancer stem cell-related therapeutics, today announces that it has adopted a shareholder rights plan (the "Plan" effective September 16, 2013. The Company will be seeking shareholder approval of the Plan at its next annual general and special meeting of shareholders.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Chemours Legal Succession Gets a Long Transition Runway

Updated Category News Views 201

A corporate-law handoff rarely sets pulses racing, but this one deserves a proper look. Chemours is replacing its long-serving general counsel while keeping the departing executive in the building for four additional months. That is not flashy, and thank goodness for that. In a global chemicals company, legal leadership touches regulation, compliance, governance,...

Continue Reading
Nvidia Faces SEC Probe Report and New Lawsuit Stakes

Updated Category News Views 40

Silicon Valley's favorite growth machine has stumbled into the sort of fog investors hate most: regulatory questions, leadership upheaval, and a stock-price reaction with no clean answer attached. Reports cited in the lawsuit update say the Securities and Exchange Commission has opened a civil probe into NVIDIA's investor disclosures following former CEO Jensen Huang's...

Continue Reading
PSEG Long Island Warns Customers on QR Payment Scams

Updated Category News Views 131

Holiday panic is a thief's favorite crowbar, and Long Island households are plainly in the crosshairs. PSEG Long Island used Utility Scam Awareness Day on Nov. 18 to warn customers about impersonators demanding immediate payment under threat of a power shutoff. The central message, “Think Before You Scan,” is not flashy corporate wallpaper. It is practical advice for...

Continue Reading
AbbaDox Finds Follow-Up Scans Lost in the Shuffle

Updated Category News Views 22

A six-month recommendation has a nasty habit of disappearing beneath today’s emergencies. That is the unglamorous, important problem AbbaDox is trying to solve in outpatient radiology: not reading the scan, but making sure a future scan recommendation actually gets reviewed, ordered, and scheduled. For investors watching healthcare operations software, this is the sort...

Continue Reading
Teciem’s New CFO Puts Financial Discipline Behind Growth

Updated Category News Views 43

A finance chief moving continents is not decorative corporate wallpaper. Teciem’s decision to appoint Jesús Rueda Molins as chief financial officer says the company wants its next growth chapter run with more than product ambition and executive slogans. It wants somebody holding the purse strings who already knows the machinery, the customers and the people making the...

Continue Reading
Radiology Staffing Gap Deepens as Imaging Demand Rises

Updated Category News Views 112

An imaging order does not mean much if nobody is available to read it, and that plain operational fact sits at the center of Medicus Healthcare Solutions' 2026 report on the radiologist shortage. The report's projected gap of 2,450 full-time-equivalent radiologists in 2027 is troubling enough. Its estimate of a 4,130 FTE shortfall by 2032 is the part that should make...

Continue Reading
SK hynix Faces Fresh DRAM Collusion Risk for Investors

Updated Category News Views 102

A Memory Market Win Can Turn Sour Fast Nothing rattles a chip story quite like the word collusion showing up beside a judge’s ruling. SK hynix had been riding a powerful memory-market narrative, but investors got a blunt reminder on November 15, 2026: a proposed U.S. class action accusing SK hynix, Samsung Electronics, and Micron of restricting DRAM supply to raise...

Continue Reading
Vail’s Board Fight Puts Strategy Under a Sharp Lens

Updated Category News Views 105

Fresh snow does not make a boardroom dispute disappear. Vail Resorts has put out an investor presentation ahead of its December 14, 2026 annual meeting, asking shareholders to support all nine of management’s director nominees on its white proxy card. That is the formal message. The real message is plainer: NYSE:MTN knows this election has become a test of whether...

Continue Reading
Candel’s BLA Delay Puts Disclosure Timing Under Fire

Updated Category News Views 0

A December filing turned into a mid-2027 wait, and Candel shareholders absorbed the damage in one ugly trading session. On November 13, shares of Candel Therapeutics fell 26% after the company disclosed that its biologics license application, or BLA, for aglatimagene in prostate cancer was no longer expected in December 2026. The revised plan is to submit in the middle of...

Continue Reading
The Hanover Survey Puts Small-Business Trust on Trial

Updated Category News Views 275

A dark storefront can apparently erase goodwill faster than plenty of owners want to admit. The Hanover Insurance Group's 2026 Small Business Pulse Report found that 60% of surveyed consumers would temporarily buy from a competitor if their preferred small business shut unexpectedly. More than half would start looking elsewhere within a week. That is not a cute...

Continue Reading

Top 5 Most Recently Viewed Articles

TCL's Innovative Initiatives: Sustainability and Creativity Unite

Updated Category News Views 304

TCL's Commitment to Innovation and Sustainability At IFA 2024, TCL, a prominent global technology brand, showcased its unwavering dedication to innovation and sustainability. This year marks TCL's 14th consecutive appearance at the event, where the company highlighted two key initiatives: TCLGreen and TCLArt. These initiatives have attracted considerable attention as they...

Continue Reading
Western Metallica Closes Private Placement to Boost Copper Projects

Updated Category News Views 209

Western Metallica's Successful Private Placement Financing Western Metallica Resources Corp. (TSXV: WMS) has successfully completed its non-brokered private placement financing. This strategic decision allowed the company to issue a significant number of units at an appealing price point. By offering 10,833,345 units at $0.03 each, Western Metallica raised gross proceeds...

Continue Reading
Astrion's New Leadership Team Set to Drive Future Innovations

Updated Category News Views 250

Astrion Unveils Dynamic Executive Leadership Team Astrion, a leader in providing advanced engineering services and mission support to government sectors, has recently announced an exciting new executive leadership team. This strategic move aligns with their ongoing mission to deliver innovative solutions following the acquisition of Axient. With industry veteran Dave...

Continue Reading
Keyera Corp. Schedules Conference Call for Q3 2024 Results

Updated Category News Views 119

Keyera Corp. Schedules 2024 Q3 Results Conference Call Keyera Corp. has announced its timeline for the release of third-quarter results. Investors and interested parties are encouraged to take note of the important dates surrounding this announcement. When to Expect the Financial Results The financial results are set to be released before the market opens on November 14,...

Continue Reading
Netflix Partners with WWE to Revitalize Global Wrestling Fanbase

Updated Category News Views 411

Netflix and WWE Join Forces for a Live Streaming Revolution In an exciting new venture, Netflix has entered the world of live programming by teaming up with World Wrestling Entertainment (WWE) to stream its flagship show, "Raw." This collaboration marks a significant shift in how wrestling fans will experience their favorite matches, bringing the thrill of live...

Continue Reading